SDI Valuation
Is SDI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SDI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SDI (A$1.08) is trading below our estimate of fair value (A$3.6)
Significantly Below Fair Value: SDI is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SDI?
Key metric: As SDI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is SDI's PE Ratio? | |
|---|---|
| PE Ratio | 12.3x |
| Earnings | AU$10.42m |
| Market Cap | AU$127.78m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.3x |
| Enterprise Value/EBITDA | 7.1x |
| PEG Ratio | 0.7x |
Price to Earnings Ratio vs Peers
How does SDI's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 37.9x | ||
NAN Nanosonics | 78.8x | 24.0% | AU$1.0b |
ANN Ansell | 39.4x | 22.8% | AU$4.7b |
AHC Austco Healthcare | 13x | n/a | AU$91.9m |
CGS Cogstate | 20.2x | 6.6% | AU$170.9m |
SDI SDI | 12.3x | 17.8% | AU$127.8m |
Price-To-Earnings vs Peers: SDI is good value based on its Price-To-Earnings Ratio (12.3x) compared to the peer average (37.9x).
Price to Earnings Ratio vs Industry
How does SDI's PE Ratio compare vs other companies in the Global Medical Equipment Industry?
| 10 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 10 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: SDI is good value based on its Price-To-Earnings Ratio (12.3x) compared to the Global Medical Equipment industry average (28.2x).
Price to Earnings Ratio vs Fair Ratio
What is SDI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 12.3x |
| Fair PE Ratio | 24.1x |
Price-To-Earnings vs Fair Ratio: SDI is good value based on its Price-To-Earnings Ratio (12.3x) compared to the estimated Fair Price-To-Earnings Ratio (24.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
SDI
AU$127.8m
Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.
SDI
AU$1.08
7D
5.9%
1Y
28.7%
Healius
AU$969.4m
Provides specialty diagnostic services to consumer and practitioners in Australia.
HLS
AU$1.33
7D
-16.1%
1Y
-27.9%
Cogstate
AU$170.9m
A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.
CGS
AU$0.98
7D
2.1%
1Y
-32.5%